Solana ETFs Approved in Switzerland: What It Means for EU Crypto Investors

U.S. stocks lost ground on Monday as a tech-led pullback weighed on the major indexes, while investors braced for a packed week of corporate earnings and a key rate decision from the European Central Bank. The S&P 500 notched its third straight daily decline, with heavyweight tech names leading the retreat. Market participants pointed to profit-taking after recent record highs and a cautious stance ahead of a crucial influx of quarterly results. ## Market Overview The **S&P 500** closed lower, slipping **0.6%** to end at **5,320**, as technology shares struggled. The **Nasdaq Composite** tumbled **1.1%**, settling near **17,950**, dragged down by megacap stocks. The **Dow Jones Industrial Average** outperformed, dipping just **0.2%** to finish at **39,380**, buoyed by defensive names. In fixed income, **Treasury yields** edged higher, with the 10-year yield rising to **4.22%**. Investors dialed back rate cut bets ahead of Thursday’s ECB meeting and after last week’s hawkish Federal Reserve commentary, which signaled officials want more evidence of cooling inflation. Commodities were mixed. **WTI crude oil** held steady near **$79.50** per barrel, as traders weighed Middle East supply risks against sluggish global demand signals. **Gold** slipped **0.4%** to **$2,380** an ounce, pressured by the stronger dollar. The **U.S. Dollar Index (DXY)** inched up to **106.2**, its highest level in three weeks. The **EUR/USD** pair hovered at **1.068**, as markets looked ahead to the ECB policy decision and fresh economic forecasts later this week. ## Key Movers The technology sector led Monday’s declines. **Nvidia (NVDA)** dropped **2.4%**, while **Apple (AAPL)** and **Alphabet (GOOGL)** each fell over **1%**. The retreat followed a period of outperformance that had pushed valuations to fresh highs, leaving stocks vulnerable to profit-taking as earnings season ramps up. Defensive sectors outperformed. Health care stocks like **Johnson & Johnson (JNJ)** and **Pfizer (PFE)** eked out small gains, as investors rotated into more stable names ahead of several key earnings reports. European robo-advisory platforms also saw muted activity, as investors awaited both the ECB’s rate decision and a slew of financial sector earnings. For those tracking robo-advisor trends, our Complete 2026 Guide to European Robo-Advisors offers a broader look at how these platforms are navigating the volatile rate environment. Meanwhile, the ongoing debate over the merits of dividend-focused robo strategies continues to shape investor preferences, as explored in our recent analysis of the pros and cons of using robo-advisors for dividend investing in Europe. ## What to Watch All eyes turn to a heavy slate of corporate earnings, with several tech giants and major banks reporting results this week. Analysts are watching for signs of margin pressure and demand trends, particularly in the semiconductor and software sectors. Thursday’s **ECB policy meeting** is front and center for global markets. Investors expect policymakers to keep rates steady, but will scrutinize President Lagarde’s comments for clues on the path ahead as inflation remains sticky and growth slows across the eurozone. Economic data releases this week include U.S. PMI readings and initial jobless claims, both of which could influence Fed rate expectations. Markets will also monitor ongoing geopolitical developments and oil supply headlines for potential shocks. As investors navigate this pivotal week, the interplay between earnings, central bank policy, and shifting risk appetites will remain in sharp focus. For a deeper dive into how European robo-advisors are responding to these market dynamics, see our comprehensive 2026 guide.